|
|
|
|
| LEADER |
02610nam a22005175i 4500 |
| 001 |
4442 |
| 003 |
DE-He213 |
| 005 |
20130726224136.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2009 xxu| s |||| 0|eng d |
| 020 |
# |
# |
|a 9780387691473
|9 978-0-387-69147-3
|
| 024 |
7 |
# |
|a 10.1007/978-0-387-69147-3
|2 doi
|
| 050 |
# |
4 |
|a RC261-271
|
| 072 |
# |
7 |
|a MJCL
|2 bicssc
|
| 072 |
# |
7 |
|a MED062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 614.5999
|2 23
|
| 100 |
1 |
# |
|a Rubin, Eric.
|e editor.
|
| 245 |
1 |
0 |
|a Modulation of Protein Stability in Cancer Therapy
|c edited by Eric Rubin, Kathleen Sakamoto.
|h [electronic resource] /
|
| 264 |
# |
1 |
|a New York, NY :
|b Springer US,
|c 2009.
|
| 300 |
# |
# |
|b online resource.
|
| 336 |
# |
# |
|a text
|b txt
|2 rdacontent
|
| 337 |
# |
# |
|a computer
|b c
|2 rdamedia
|
| 338 |
# |
# |
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
# |
# |
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
# |
|a Protacs chimeric molecules to target cancer causing proteins for ubiquitination and degradation -- Topors and sumoylation in cancer therapy -- Ubistatins -- Novel roteasome inhibitors -- MDM2 inhibitors -- HSP90 inhibitors in cancer therapy -- Novel proteasome inhibitors in multiple myeloma -- Novel HDAC6 inhibitor -- Histone deacetylase inhibitors in prostate cancer -- The role of ISG15 in carcinogenesis.
|
| 520 |
# |
# |
|a This book contains chapters written by experts in the field of the ubiquitin proteasome system and cancer. The authors have summarized current information on ubiquitin ligases and proteasomes as potential targets for cancer therapy. Topics covered in the book include an overview of ubiquitin ligases, deubiquitinating enzymes, and the proteasome. Specific diseases resulting from deregulated ubiquitin ligases, such as Von-Hippel-Lindau disease and Fanconi anemia are also discussed. Finally, novel approaches and drugs to target proteins involved in sumoylation, ubiquitination, and degradation are described.
|
| 650 |
# |
0 |
|a Medicine.
|
| 650 |
# |
0 |
|a Oncology.
|
| 650 |
# |
0 |
|a Human genetics.
|
| 650 |
# |
0 |
|a Immunology.
|
| 650 |
# |
0 |
|a Microbiology.
|
| 650 |
# |
0 |
|a Biochemistry.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Medical Microbiology.
|
| 650 |
2 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Biochemistry, general.
|
| 700 |
1 |
# |
|a Sakamoto, Kathleen.
|e editor.
|
| 710 |
2 |
# |
|a SpringerLink (Online service)
|
| 773 |
0 |
# |
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9780387691435
|
| 856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-0-387-69147-3
|
| 912 |
# |
# |
|a ZDB-2-SBL
|
| 950 |
# |
# |
|a Biomedical and Life Sciences (Springer-11642)
|